QuilliChew ER Interactions
There are 207 drugs known to interact with QuilliChew ER (methylphenidate), along with 14 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 23 are major, 173 are moderate, and 11 are minor.
- View all 207 medications that may interact with QuilliChew ER
- View QuilliChew ER alcohol/food interactions (4)
- View QuilliChew ER disease interactions (14)
Most frequently checked interactions
View interaction reports for QuilliChew ER (methylphenidate) and the medicines listed below.
- Abilify (aripiprazole)
- Adderall (amphetamine / dextroamphetamine)
- amantadine
- buspirone
- cetirizine
- clonidine
- cyclobenzaprine
- Depakote (divalproex sodium)
- duloxetine
- escitalopram
- fluoxetine
- Focalin (dexmethylphenidate)
- Focalin XR (dexmethylphenidate)
- gabapentin
- guanfacine
- hydroxyzine
- Intuniv (guanfacine)
- Klonopin (clonazepam)
- lamotrigine
- Lexapro (escitalopram)
- melatonin
- MiraLAX (polyethylene glycol 3350)
- omeprazole
- Prozac (fluoxetine)
- risperidone
- Strattera (atomoxetine)
- trazodone
- Vitamin D3 (cholecalciferol)
- Vyvanse (lisdexamfetamine)
- Zoloft (sertraline)
QuilliChew ER alcohol/food interactions
There are 4 alcohol/food interactions with QuilliChew ER (methylphenidate).
QuilliChew ER disease interactions
There are 14 disease interactions with QuilliChew ER (methylphenidate) which include:
- agitation
- cardiac disease
- glaucoma
- hypertension
- psychiatric disorders
- substance abuse
- tics
- hypertension
- seizures disorders
- liver disease
- renal dysfunction
- seizure disorders
- hematologic toxicity
- GI narrowing
Report options
QR code containing a link to this page
More about QuilliChew ER (methylphenidate)
- QuilliChew ER consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CNS stimulants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
